While not all hepatomas demonstrate hyperglycolysis, tumor glycolytic activity in HCC has been correlated with HK2 expression in tumors and the risk of cancer recurrence [14]–[17]. The gene discussed is HK2; the disease is hepatocellular carcinoma.